Core Points - The company, China Merchants Highway Network Technology Holdings Co., Ltd., has successfully redeemed its first phase of medium-term notes for the year 2022, which matured on August 3, 2025 [2][3] - The total registered amount for the medium-term notes was 6 billion yuan, with a specific issuance of 2 billion yuan at an interest rate of 2.68% for a term of 3 years [1] Summary by Sections - **Company Announcement**: The company assures that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1] - **Medium-Term Notes Registration**: The company received approval for the registration of medium-term notes amounting to 6 billion yuan, valid for 2 years [1] - **Issuance Details**: The first phase of medium-term notes was issued on August 1-2, 2022, with a total scale of 2 billion yuan and an interest rate of 2.68% [1] - **Redemption Confirmation**: The company confirmed the successful payment of principal and interest for the medium-term notes on the maturity date [2]

Group 1 - The company, Nanjing Pharmaceutical Co., Ltd., has announced the issuance of its first medium-term note for 2023, with a total issuance amount of 100,000 million yuan [1] - The bond, named "23 Nanjing Pharmaceutical MTN001," has an interest rate of 3.1% and a maturity date set for June 20, 2025 [1] - The main underwriters for this bond issuance are Bank of Communications Co., Ltd. and Industrial Bank Co., Ltd. [1] Group 2 - The bond's interest and principal repayment will be managed by the China Interbank Market Clearing House Co., Ltd., which will transfer funds to bondholders on the specified payment date [1] - In case the payment date falls on a public holiday, the payment will be postponed accordingly [1] - The company and the clearing house will not be liable for any losses incurred due to delays in fund transfers if bondholders fail to notify changes in their payment account in a timely manner [1]